307 related articles for article (PubMed ID: 24423476)
41. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
42. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
43. Retrograde Popliteal Access and Balloon Dilatation of Chronic Total Occlusion of Superficial Femoral Arteries.
Kuserli Y; Kavala AA
Ann Vasc Surg; 2020 Apr; 64():253-262. PubMed ID: 31634601
[TBL] [Abstract][Full Text] [Related]
44. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
[TBL] [Abstract][Full Text] [Related]
45. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
[TBL] [Abstract][Full Text] [Related]
46. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
[TBL] [Abstract][Full Text] [Related]
47. Safety, clinical outcome, and fracture rate of femoropopliteal stenting using a 4F compatible delivery system.
Sarkadi H; Bérczi V; Kollár A; Kiss D; Jakabfi P; Végh EM; Nemes B; Merkely B; Hüttl K; Dósa E
Eur J Vasc Endovasc Surg; 2015 Feb; 49(2):199-204. PubMed ID: 25579877
[TBL] [Abstract][Full Text] [Related]
48. Sustained Effectiveness of Cilostazol After Endovascular Treatment of Femoropopliteal Lesions: Midterm Follow-up From the Sufficient Treatment of Peripheral Intervention by Cilostazol (STOP-IC) Study.
Soga Y; Hamasaki T; Edahiro R; Iida O; Inoue N; Suzuki K; Yokoi Y; Kawasaki D; Zen K; Urasawa K; Aodo K;
J Endovasc Ther; 2018 Jun; 25(3):306-312. PubMed ID: 29706129
[TBL] [Abstract][Full Text] [Related]
49. Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study.
Schmidt A; Zeller T; Sievert H; Krankenberg H; Torsello G; Stark MA; Scheinert D
J Endovasc Ther; 2014 Feb; 21(1):52-60. PubMed ID: 24502484
[TBL] [Abstract][Full Text] [Related]
50. Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system.
Powell RJ; Jaff MR; Schroë H; Benko A; Diaz-Cartelle J; Müller-Hülsbeck S
Catheter Cardiovasc Interv; 2017 May; 89(6):1069-1077. PubMed ID: 28296239
[TBL] [Abstract][Full Text] [Related]
51. The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.
Teichgräber U; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Thieme M; Blessing E; Treitl M; Lichtenberg M; von Flotow P; Vogel B; Werk M; Riambau V; Wienke A; Lehmann T; Sixt S
Trials; 2016 Oct; 17(1):528. PubMed ID: 27793175
[TBL] [Abstract][Full Text] [Related]
52. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
Chan YC; Cheng SW; Cheung GC
J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
[TBL] [Abstract][Full Text] [Related]
53. Duplex-guided balloon angioplasty and stenting for femoropopliteal arterial occlusive disease: an alternative in patients with renal insufficiency.
Ascher E; Marks NA; Schutzer RW; Hingorani AP
J Vasc Surg; 2005 Dec; 42(6):1108-13. PubMed ID: 16376200
[TBL] [Abstract][Full Text] [Related]
54. The use of the GORE® TIGRIS® Vascular Stent with dual component design in the superficial femoral and popliteal arteries at 6 months.
Piorkowski M; Freitas B; Schmidt A; Bräunlich S; Ulrich M; Schuster J; Bausback Y; Werner M; Scheinert D
J Cardiovasc Surg (Torino); 2013 Aug; 54(4):447-53. PubMed ID: 24013533
[TBL] [Abstract][Full Text] [Related]
55. Combination of Percutaneous Rotational Thrombectomy and Drug-Coated Balloon for Treatment of Femoropopliteal Artery Nonembolic Occlusion: 12-Month Follow-up.
Wang Q; Zhu RM; Ren HL; Leng R; Zhang WD; Li CM
J Vasc Interv Radiol; 2020 Oct; 31(10):1661-1667. PubMed ID: 32921564
[TBL] [Abstract][Full Text] [Related]
56. Provisional focal stenting of complex femoropopliteal lesions using the Multi-LOC multiple stent delivery system - 12-month results from the LOCOMOTIVE EXTENDED study.
Amendt K; Zeller T; Proczka R; Beschorner U; Troisi N; Waliszewski M; Langhoff R; Krankenberg H; Hansch A; Krcmar T; Vidjak V; Nolte-Ernsting C; Hansen A; Sigl M
Vasa; 2021 Apr; 50(3):209-216. PubMed ID: 33238823
[No Abstract] [Full Text] [Related]
57. Early outcomes of novel Temren atherectomy device combined with drug-coated balloon angioplasty for treatment of femoropopliteal lesions.
Yiğit G
Vascular; 2022 Aug; 30(4):739-748. PubMed ID: 34180304
[TBL] [Abstract][Full Text] [Related]
58. 4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial.
Bosiers M; Deloose K; Callaert J; Keirse K; Verbist J; Hendriks J; Lauwers P; D'Archambeau O; Scheinert D; Torsello G; Peeters P
J Endovasc Ther; 2013 Dec; 20(6):746-56. PubMed ID: 24325689
[TBL] [Abstract][Full Text] [Related]
59. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.
Shammas NW; Shammas GA; Helou TJ; Voelliger CM; Mrad L; Jerin M
Cardiovasc Revasc Med; 2012; 13(4):224-7. PubMed ID: 22575073
[TBL] [Abstract][Full Text] [Related]
60. Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.
Iida O; Urasawa K; Komura Y; Soga Y; Inoue N; Hara H; Yajima J; Nakamura S; Ohki T; Ando H; Hirano K; Horita Y; Kichikawa K; Yokoi Y; Miyamoto A; Nakamura M; Takahara M; Mano T; Nanto S
J Endovasc Ther; 2019 Apr; 26(2):158-167. PubMed ID: 30702021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
